A series of 5-6 fused ring bicyclic heteroaromatic derivatives, based in
particular on the 6-oxo-6,7-dihydrothieno[2,3-b]pyridine ring system,
being inhibitors of p38 kinase, are accordingly of use in medicine, for
example in the treatment and/or prevention of immune or inflammatory
disorders.